Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Sinus is also called as chronic rhinosinusitis, it is a disorder in which cavities around nasal known as (sinuses) get inflamed and swollen for weeks. The people suffering from sinus may have signs such as nasal block, tenderness, swelling of the face, sore throat, nausea, fatigue and pain in jaw and teeth. In addition, one of the innovative sinus dilation procedure is the balloon sinus dilation, a minimally invasive technique that replaces the out-dated sinus surgeries procedure. However, new devices have been established that do not utilize balloon dilation, but allow for a more gradual dilation through an osmotic process using the body’s natural mucosal fluids to increase the insert before removal. This technique is mentioned to as self-expanding absorptive sinus ostial dilation. Furthermore, according to the American Cancer Society, cancers of the paranasal sinuses and nasal cavity are rare, and affect nearly 2,000 people in the U.S. each year. Thus, mounting rate of chronic sinusitis provides high growth potential to the players working in sinus dilation devices market thereby expanding the business growth globally.
High prevalence of chronic sinusitis, advancements in technology and favorable reimbursement scenario are the factors driving the market growth. In addition, key players are taking strategic decisions to gain market share in cell-based research is also expected to fuel the growth of sinus dilation devices market. However, growing healthcare market in emerging economies is one factor hampering the growth of the market.
The sinus dilation devices market is segmented product, type of procedure, patient type, end user and geography
On the basis of product, the sinus dilation devices market is segmented into balloon sinus dilation devices, endoscopes, sinus stents/implants and handheld instruments. The Endoscopes segment is further classified into sinuscopes and rhinoscopes. Balloon Sinuplasty (BSP) uses a small, flexible, balloon catheter to open up blocked sinus passageways and facilitate drainage of the mucus that builds up in patients suffering from chronic sinusitis symptoms.
Based on the type of procedure, the sinus dilation devices market is bifurcated into standalone sinus dilation procedures and hybrid sinus dilation procedures. Among these, the standalone sinus dilation procedures segment dominated the market in 2018, owing to the benefits presented by standalone procedures such as quick relief and decrease in long-lasting cold symptoms and blocked nose.
The patient type studied in this report are adult and pediatric. The adult segment accounted for the largest market share owing to the increase in the prevalence of sinusitis among adults. In addition, this segment is also attributed due to the increasing ageing population around the world.
The end user of the sinus dilation devices market is segmented into hospitals, ambulatory surgical centers and ENT clinics/in office. The hospitals segment dominated the market due to the availability of technologically advanced infrastructures, benefits of having combined healthcare facilities and the capability to perform complex sinus operations.
Geographically, the global sinus dilation devices market is diversified into North America, Europe, Asia-Pacific and rest of the world. The North America region dominated the sinus dilation devices market in the 2018, owing to increasing prevalence of chronic sinusitis, greater adoption of new technologies among ENT specialists. However, Asia Pacific is projected to emerge as the most promising region during the forecast period.
The key companies operating in the market are Entellus Medical Inc. (A Subsidiary of Stryker), Medtronic, Acclarent, Inc. (A Subsidiary of Johnson & Johnson), Smith & Nephew PLC, Intersect ENT, Inc., Sinusys Corporation, Innaccel Pvt. Ltd, Meril Life Sciences Pvt Ltd., Jilin Coronado Medical Ltd., Dalent LLC., Creganna Medical., Olympus. New product launches, mergers & acquisitions are the key strategies adopted by market players to ensure their growth in the market.
The sinus dilation devices market is segmented product, type of procedure, patient type, end user and geography. On the basis of product, the sinus dilation devices market is segmented into balloon sinus dilation devices, endoscopes, sinus stents/implants and handheld instruments. The Endoscopes segment is further classified into sinuscopes and rhinoscopes. Balloon Sinuplasty (BSP) uses a small, flexible, balloon catheter to open up blocked sinus passageways and facilitate drainage of the mucus that builds up in patients suffering from chronic sinusitis symptoms.
By type of procedure, the sinus dilation devices market is bifurcated into standalone sinus dilation procedures and hybrid sinus dilation procedures. Among these, the standalone sinus dilation procedures segment dominated the market in 2018, owing to the benefits presented by standalone procedures such as quick relief and decrease in long-lasting cold symptoms and blocked nose.
The patient type studied in this report are adult and Pediatric. The adult segment accounted for the largest market share owing to the increase in the prevalence of sinusitis among adults. In addition, this segment is also attributed due to the increasing ageing population around the world.
The end user of the sinus dilation devices market is segmented into hospitals, ambulatory surgical centers and ENT clinics/in office. The hospitals segment dominated the market due to the availability of technologically advanced infrastructures, benefits of having combined healthcare facilities and the capability to perform complex sinus operations.
Geographically, the global sinus dilation devices market is diversified into North America, Europe, Asia-Pacific and rest of the world. The North America region dominated the sinus dilation devices market in the 2018, owing to increasing prevalence of chronic sinusitis, greater adoption of new technologies among ENT specialists. However, Asia Pacific is projected to emerge as the most promising region during the forecast period.
Why to buy this report:
